At a glance
ClinicalIndex Comparison RecordN/ACompleted· 195 enrolled
Drug / intervention
Diabetes Journey +1 morebehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Diabetes Journey: An Intervention to Improve Adherence Barriers for Adolescents With Type 1 Diabetes
Children's Hospital Medical Center, Cincinnati·interventional·Posted May 27, 2020·Updated Jul 15, 2025
In Brief
A clinical study evaluating Diabetes Journey and Enhanced Standard of Care for Type 1 Diabetes and Adherence, Patient. Completed, enrolled 195 participants across 2 sites.
Detailed Summary
The purpose of this study is to examine the feasibility, acceptability, and preliminary efficacy of a web-based intervention addressing adherence barriers in adolescents with T1D.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsType 1 Diabetes, Adherence, Patient
CountriesUnited States
Timeline
N/ACompletedFinished
202120222023202420252026
First PostedMay 2020
Enrollment StartAug 2020
Primary CompletionMar 2024
TodayJul 2026
First PostedMay 27, 2020
Enrollment StartAug 10, 2020
Primary CompletionMar 31, 2024
TodayJul 2, 2026
Enrollment to primary: 3.6 yearsPosted 6.1 years ago
Interventions
Diabetes Journeybehavioral
Web-based telehealth intervention focused on adherence barriers and problem-solving
Enhanced Standard of Carebehavioral
General education via the T1DToolkit website, as well as 4 phone calls with certified diabetes educators (CDEs) will be provided.